Difference in Serological Marker Profile of Fontan Patients with Decompensated Heart Failure

نویسندگان
چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Erratum: Serum bilirubin as a prognostic marker in patients with acute decompensated heart failure

BACKGROUND/AIMS Several prognostic markers for heart failure (HF) have been determined but the importance of liver function tests (LFTs) remains unknown. The aim of this study was to determine the prognostic significance, if any, of abnormal LFTs in acute decompensated HF. METHODS All adult patients (> 18 years of age) who were admitted to a community hospital with a diagnosis of acute decomp...

متن کامل

Management of acute decompensated heart failure in patients with cancer.

Case Study: H.M. is a 70-year-old woman with a known history of metastatic breast cancer. In 1995, she underwent a right modifi ed radical mastectomy followed by four years of hormonal therapy with tamoxifen. In April 2001, she was diagnosed with bone metastases and placed on letrozole, zoledronic acid, and chemotherapy consisting of gemcitabine and docetaxel. She experienced severe mucositis, ...

متن کامل

The Role of Ultrafiltration in Patients with Decompensated Heart Failure

Congestion, due in large part to hypervolemia, is the primary driver of heart failure (HF) admissions. Relief of congestion has been traditionally achieved through the use of loop diuretics, but there is increasing concern that these agents, particularly at high doses, may be deleterious in the inpatient setting. In addition, patients with HF and the cardiorenal syndrome (CRS) have diminished r...

متن کامل

Diuretic strategies in patients with acute decompensated heart failure.

BACKGROUND Loop diuretics are an essential component of therapy for patients with acute decompensated heart failure, but there are few prospective data to guide their use. METHODS In a prospective, double-blind, randomized trial, we assigned 308 patients with acute decompensated heart failure to receive furosemide administered intravenously by means of either a bolus every 12 hours or continu...

متن کامل

Endothelial cell activation in patients with decompensated heart failure.

BACKGROUND Vascular endothelial functions, other than nitric oxide (NO)-mediated control of vasomotor tone, are poorly characterized in patients with chronic heart failure (CHF). Veins and arteries are exposed to the same circulating proinflammatory mediators in patients with CHF. The present study tested whether endothelial cell activation occurs in veins of patients with decompensated CHF and...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Journal of Cardiac Failure

سال: 2019

ISSN: 1071-9164

DOI: 10.1016/j.cardfail.2019.07.544